🇺🇸 FDA

Company profile · Sponsor

Gilead

Gilead Sciences Ireland UC

E9A4A70 · EMA pharma IE
Pipeline
24
Drugs
0
Patents
0

Quick answer

Gilead (E9A4A70) is a pharma company. headquartered in IE. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E9A4A70
Exchange EMA
Company type pharma
Headquarters IE

Pipeline (24)

Search pipeline →

  1. AZLI 75 mg two times a day (BID)/ three times a day (TID)

    Gilead

    Cystic Fibrosis

    phase 3 small molecule completed

    1 trial

  2. B/F/TAF

    Gilead

    HIV-1/HBV Co-Infection

    phase 3 small molecule completed

    1 trial

  3. B/F/TAF (Adult Strength)

    Gilead

    HIV-1 Infection

    phase 3 small molecule active

    1 trial

  4. Bictegravir

    Gilead

    HIV-1-infection

    phase 3 small molecule active

    2 trials

  5. COBI

    Gilead

    HIV

    phase 3 small molecule completed

    1 trial

  6. E/C/F/TDF

    Gilead

    Acquired Immunodeficiency Syndrome

    phase 3 small molecule completed

    1 trial

  7. LDV/SOF

    Gilead

    Hepatitis C Virus

    phase 3 small molecule completed

    1 trial

  8. SOF/VEL

    Gilead

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    3 trials

  9. SOF/VEL/VOX

    Gilead

    Hepatitis C Virus Infection

    phase 3 small molecule completed

    1 trial

  10. Sacituzumab Govitecan-hziy

    Gilead

    Triple Negative Breast Cancer

    phase 3 small molecule active

    1 trial

  11. Sofosbuvir

    Gilead

    Hepatitis C

    phase 3 small molecule completed

    2 trials

  12. Sofosbuvir

    Gilead

    Chronic HCV Infection

    phase 3 small molecule completed

    1 trial

  13. Tenofovir DF

    Gilead

    Chronic Hepatitis B

    phase 3 small molecule active

    1 trial

  14. Andecaliximab

    Gilead

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  15. BSF 208075

    Gilead

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  16. Presatovir

    Gilead

    Respiratory Syncytial Virus

    phase 2 small molecule completed

    1 trial

  17. SOF

    Gilead

    HCV Infection

    phase 2 small molecule completed

    1 trial

  18. SOF

    Gilead

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial

  19. VOX

    Gilead

    Hepatitis C Virus Infection

    phase 2 small molecule completed

    1 trial

  20. B/F/TAF

    Gilead

    HIV-1-infection

    phase 1 small molecule completed

    1 trial

  21. Evixapodlin

    Gilead

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  22. GS-0272

    Gilead

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial

  23. GS-2829

    Gilead

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial

  24. Lanraplenib.

    Gilead

    Inflammatory Disease

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Gilead?

Gilead (E9A4A70) is a pharma company. headquartered in IE. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Gilead sponsor?

We track 24 ClinicalTrials.gov-linked programs for Gilead, including AZLI 75 mg two times a day (BID)/ three times a day (TID) and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Gilead company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.